Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
Metastatic triple-negative breast cancer (TNBC) is a heterogeneous disease with a poor prognosis and currently with few treatment options. Treatment of these patients is highly based on systemic chemotherapy. Some targeted drugs were recently approved for these patients: two poly(ADP-ribose) polymer...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2021-03-01
|
| Col·lecció: | Breast Cancer: Basic and Clinical Research |
| Accés en línia: | https://doi.org/10.1177/11782234211002491 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|